Department of Molecular Pharmacology and Radiobiology, Pirogov Russian National Research Medical University, Moscow, Russia.
Curr Cancer Drug Targets. 2024;24(11):1089-1103. doi: 10.2174/0115680096282480240105071638.
Chronic inflammation is associated with a prolonged increase in various inflammatory factors. According to clinical data, it can be linked with both cancer and autoimmune diseases in the same patients. This raises the critical question of how chronic inflammation relates to seemingly opposing diseases - tumors, in which there is immunosuppression, and autoimmune diseases, in which there is over-activation of the immune system. In this review, we consider chronic inflammation as a prerequisite for both immune suppression and an increased likelihood of autoimmune damage. We also discuss potential disease-modifying therapies targeting chronic inflammation, which can be helpful for both cancer and autoimmunity. On the one hand, pro-inflammatory factors persisting in the areas of chronic inflammation stimulate the production of anti-inflammatory factors due to a negative feedback loop, eliciting immune suppression. On the other hand, chronic inflammation can bring the baseline immunity closer to the threshold level required for triggering an autoimmune response using the bystander activation of immune cells. Focusing on the role of chronic inflammation in cancer and autoimmune diseases may open prospects for more intensive drug discovery for chronic inflammation.
慢性炎症与各种炎症因子的长期增加有关。根据临床数据,它可以与同一患者的癌症和自身免疫性疾病相关联。这就提出了一个关键问题,即慢性炎症如何与看似对立的疾病(肿瘤,其中存在免疫抑制,和自身免疫性疾病,其中存在免疫系统过度激活)相关联。在这篇综述中,我们将慢性炎症视为免疫抑制和自身免疫损伤可能性增加的先决条件。我们还讨论了针对慢性炎症的潜在疾病修饰治疗方法,这些方法对癌症和自身免疫性疾病都有帮助。一方面,由于负反馈循环,持续存在于慢性炎症区域的促炎因子会刺激抗炎因子的产生,从而引发免疫抑制。另一方面,慢性炎症可以通过免疫细胞的旁观者激活,使基线免疫接近触发自身免疫反应所需的阈值水平。关注慢性炎症在癌症和自身免疫性疾病中的作用可能为慢性炎症的更深入药物发现开辟前景。